TY - JOUR
T1 - Complete histologic normalisation is associated with reduced risk of relapse among patients with ulcerative colitis in complete endoscopic remission
AU - Cushing, Kelly C.
AU - Tan, William
AU - Alpers, David H.
AU - Deshpande, Vikram
AU - Ananthakrishnan, Ashwin N.
N1 - Funding Information:
Funding information Ananthakrishnan is funded by the Crohn's and Colitis Foundation, National Institutes of Health (R03 DK112909) and the Chleck Family Foundation. This work is supported by the National Institutes of Health (P30 DK043351) to the Center for Study of Inflammatory Bowel Diseases. Declaration of personal interests: Kelly Cushing and William Tan have no conflict of interests to declare. David Alpers: Consulting for Pfizer, GSK, Otsuka North America, Takeda North America. Vikram Deshpande: Consulting for Agios; research support ACD. Ashwin Ananthakrishnan has served on scientific advisory boards for Abbvie, Gilead, Takeda and Merck.
Publisher Copyright:
© 2019 John Wiley & Sons Ltd
PY - 2020/2/1
Y1 - 2020/2/1
N2 - Background: Clinical and endoscopic remission are treatment targets in ulcerative colitis (UC). The value of histologic healing in altering clinical outcomes among patients with complete endoscopic healing is not well established. Aim: To quantify the association between histologic activity and clinical relapse among patients with UC who were in complete endoscopic remission. Methods: This study included patients with UC from a prospective registry who were in complete endoscopic remission. Histologic activity was quantified by a senior gastrointestinal pathologist. Histologic activity was defined as lack of normalisation (Geboes score > 0) as well as histologically active disease (Geboes score ≥2.1 and ≥3.1). The primary outcome was clinical relapse within 2 years. Multivariable regression adjusting for potential confounders examined the independent predictive value of histologic changes. Results: The study included 83 patients (51% women) (median age 44 years; median disease duration 11 years). Forty-one (49%) had complete histologic normalisation. Within two years, 26 (31%) experienced clinical relapse. Patients with complete histologic normalisation were less likely to experience relapse (5/41, 12%) compared to those without normalisation (21/42, 50%, P < 0.001) (multivariable OR 7.22, 95% confidence interval (CI) 2.48-24.70) by the Geboes score. The individual components of the Geboes score predictive of relapse were architectural changes (P = 0.03) and increased chronic inflammatory infiltrate (P < 0.001). Conclusions: Complete histologic healing using the Geboes score was associated with reduced rates of clinical relapse among patients with UC in endoscopic remission.
AB - Background: Clinical and endoscopic remission are treatment targets in ulcerative colitis (UC). The value of histologic healing in altering clinical outcomes among patients with complete endoscopic healing is not well established. Aim: To quantify the association between histologic activity and clinical relapse among patients with UC who were in complete endoscopic remission. Methods: This study included patients with UC from a prospective registry who were in complete endoscopic remission. Histologic activity was quantified by a senior gastrointestinal pathologist. Histologic activity was defined as lack of normalisation (Geboes score > 0) as well as histologically active disease (Geboes score ≥2.1 and ≥3.1). The primary outcome was clinical relapse within 2 years. Multivariable regression adjusting for potential confounders examined the independent predictive value of histologic changes. Results: The study included 83 patients (51% women) (median age 44 years; median disease duration 11 years). Forty-one (49%) had complete histologic normalisation. Within two years, 26 (31%) experienced clinical relapse. Patients with complete histologic normalisation were less likely to experience relapse (5/41, 12%) compared to those without normalisation (21/42, 50%, P < 0.001) (multivariable OR 7.22, 95% confidence interval (CI) 2.48-24.70) by the Geboes score. The individual components of the Geboes score predictive of relapse were architectural changes (P = 0.03) and increased chronic inflammatory infiltrate (P < 0.001). Conclusions: Complete histologic healing using the Geboes score was associated with reduced rates of clinical relapse among patients with UC in endoscopic remission.
UR - http://www.scopus.com/inward/record.url?scp=85074828113&partnerID=8YFLogxK
U2 - 10.1111/apt.15568
DO - 10.1111/apt.15568
M3 - Article
C2 - 31696961
AN - SCOPUS:85074828113
SN - 0269-2813
VL - 51
SP - 347
EP - 355
JO - Alimentary Pharmacology and Therapeutics
JF - Alimentary Pharmacology and Therapeutics
IS - 3
ER -